Eric Shaff

Eric Shaff currently serves as the President and Chief Executive Officer, bringing over two decades of expertise in biotechnology finance, corporate development, and capital markets. Previously, he held the position of Executive Vice President, Chief Operating and Financial Officer at Seres. His extensive background includes roles such as Vice President, Corporate Finance at Momenta Pharmaceuticals and Vice President, Finance of Genzyme’s Rare Genetic Disease Division. Additionally, Shaff has experience in corporate finance at Pfizer and in investment banking at Broadview International, now part of Jefferies LLC. He also serves on the board of directors of Sigilon Therapeutics, Inc. Shaff’s academic credentials include a B.A. in political science and economics from the University of Pennsylvania and an MBA with a finance concentration from the Johnson Graduate School of Management at Cornell University.